Hollis, NH, United States of America

David C Nivens

This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Deka Products Limited Partnership. Active years: 2020-2025.

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Biography of David C Nivens

Introduction: David C Nivens is an accomplished inventor based in Hollis, NH (US). He holds a total of six patents, showcasing his innovative contributions to the field of bioreactor technology and medical devices.

Latest Patents: Among his latest patents is a system and method for characterizing bioreactor fluids. This invention features a magnetic resonance device designed to monitor the growth of tissue in bioreactors. The device includes two magnets that create a uniform magnetic field around samples of effluent from bioreactors. A controller commands an RF signal to illuminate the magnetized sample, while sensors detect echo signals to characterize the sample. Another notable patent is a medical pump designed for patient treatment. This pump incorporates a spring-biased plunger, a cam shaft for actuation, and a lever that operates between closed and open positions, ensuring effective medication delivery.

Career Highlights: David C Nivens is currently associated with Deka Products Limited Partnership, where he applies his expertise in developing advanced medical technologies. His work has significantly impacted the medical field, particularly in enhancing patient care through innovative devices.

Collaborations: Throughout his career, Nivens has collaborated with notable colleagues, including David Blumberg, Jr. and Michael C Tilley. These partnerships have fostered a creative environment that encourages the development of groundbreaking inventions.

Conclusion

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…